# BRIEFING — 2026-11-10T02:18:30Z

## Mission
Fix neutrophil and B-cell transendothelial pore transit state machines in `microDefend/script.js` as detailed in Challenger 2 Gap Report, ensuring all E2E and invariant tests pass.

## 🔒 My Identity
- Archetype: teamwork_worker
- Roles: implementer, qa, specialist
- Working directory: c:\Users\user\Documents\GitHub\chihhsiangchien.github.io\microDefend
- State folder: c:\Users\user\Documents\GitHub\chihhsiangchien.github.io\.agents\teamwork\worker_remediation_m5\
- Original parent: 32a0c603-1575-4885-9451-54425e714562
- Milestone: Milestone 5 Phase 2 Adversarial Hardening

## 🔒 Key Constraints
- Exclusively owns: `microDefend/script.js`
- Integrity Mandate: No dummy, hardcoded or facade implementations.
- Verify through automated test suites: Python stdlib & Node CDP.

## Current Parent
- Conversation ID: 32a0c603-1575-4885-9451-54425e714562
- Updated: 2026-11-10T02:18:30Z

## Task Summary
- **What to build**: Fix pore transit state machines for Neutrophils and B-cells in `microDefend/script.js`.
- **Success criteria**: All tests (`test_challenger2_invariants.py`, `test_microdefend_e2e.py`, `test_cdp_e2e.js`, `test_challenger2_cdp.js`) pass.
- **Interface contracts**: PROJECT.md
- **Code layout**: PROJECT.md

## Key Decisions Made
- Reordered state machine branches in `microDefend/script.js` for both neutrophils (lines 8072-8104) and B cells (lines 7994-8026) so that the squeezing phase takes precedence over distance evaluation to the pore entry, preventing backward pull oscillations.
- Updated `tests/test_challenger2_invariants.py` to assert that 24/24 mobilized neutrophils successfully intravasate and that both codebases include prioritized squeezing gating.

## Artifact Index
- `DISPATCH.md` — Initial assignment
- `progress.md` — Liveness & status tracking
- `handoff.md` — Final completion report

## Change Tracker
- **Files modified**:
  - `microDefend/script.js`: Prioritized `squeezing` state machine in B-cell and neutrophil sinusoidal intravasation loops.
  - `tests/test_challenger2_invariants.py`: Verified remediated simulation and code AST/content.
- **Build status**: Pass (100% test passing rate across all 4 suites)
- **Pending issues**: None

## Quality Status
- **Build/test result**: Pass (12/12 invariants, 15/15 unit tests, 18/18 CDP E2E, 5/5 Challenger CDP)
- **Lint status**: Clean
- **Tests added/modified**: `test_identify_pore_intravasation_oscillation_flaw` converted to remediation verification suite
